By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Infinity Pharmaceuticals Inc. 

780 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-453-1000 Fax: 617-453-1001

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation.

Small molecule discovery and development capabilities
Infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation.

Strategic alliances
Building on its strengths in innovative small molecule drug discovery and development, Infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline.

Business and scientific expertise
The company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business and drug discovery and development.

Culture of Citizen-Ownership
Infinity’s culture and environment of Citizen-Ownership is as important as its technologies. Infinity works together as a community with the shared goal of bringing important new medicines to patients.

Key Statistics

Ownership: Public

Web Site: Infinity Pharma
Employees: 180
Symbol: INFI



Company News
Infinity Pharma (INFI) Provides Company Update And Reports First Quarter 2017 Financial Results 5/10/2017 10:53:10 AM
Infinity Pharma (INFI) Announces The Date Of Its First Quarter 2017 Financial Results Conference Call And Webcast 4/26/2017 10:52:03 AM
Infinity Pharma (INFI) Release: Updated Phase 1 Data For IPI-549 Presented At AACR Annual Meeting 2017 4/3/2017 6:39:04 AM
Infinity Pharma (INFI) Provides Company Update and Reports Fourth Quarter 2016 Financial Results 3/15/2017 10:03:18 AM
Infinity Pharma (INFI) Announces The Date Of Its Full-Year 2016 Financial Results Conference Call And Webcast 2/28/2017 8:56:02 AM
Infinity Pharma (INFI) Announces Promotion Of Jeffery Kutok, M.D., Ph.D. To Chief Scientific Officer 2/13/2017 7:00:36 AM
Infinity Pharma (INFI) Release: Company Presents Preclinical Data And Phase 1 Clinical Data On IPI-549 At PI3K Keystone Symposia Conference 1/20/2017 10:10:33 AM
Infinity Pharma (INFI) Provides 2017 Goals And Financial Guidance 1/9/2017 10:53:12 AM
Infinity Pharma (INFI) Promotes a Handful of Execs, Announces Retirement of R&D Head Effective Jan. 6 1/4/2017 6:36:43 AM
Infinity Pharma (INFI) Provides Company Update And Reports Third Quarter 2016 Financial Results 11/10/2016 4:54:11 PM